肥厚性・ケロイド性傷跡治療市場規模：傷跡タイプ別（肥厚性傷跡、ケロイド性傷跡）、製品別（局所製品、レーザー製品、注射剤）、エンドユーザー別、セグメント別予測、2022年～2030年

肥大性・ケロイド性瘢痕治療市場の成長と動向

グランドビューリサーチ社の最新レポートによると、肥大・ケロイド痕治療市場規模は、2030年までに146億米ドルに達し、予測期間中に8.47%のCAGRを示すと予想されているそうです。

これは、交通事故や火傷の件数が増加していることに起因しています。例えば、米国火傷協会の記事によると、毎年40万人以上の人が火傷の治療を受けています。同様に、子供の安全ネットワークに従って、毎年10万人以上の子供＆青年は、火傷の負傷のために治療されています。

さらに、米国道路交通安全局（National Highway Traffic Safety Administration）によると、2021年の最初の9カ月間で、推定31,720人が交通事故で死亡しています。この数は、2020年と比較して12％増加しています。同様に、Live Mintによると、2020年にインドから報告された交通事故は3,54,796件です。したがって、上記の要因から、t市場は予測期間中に大きな成長を遂げると推定されます。

同様に、美的魅力と手術の可用性に関する意識の高まりが、業界の成長を後押しすると予想されます。例えば、Medscapeによると、世界では2億回の切開が行われています。さらに、同様のソースによると、推定17万件の傷跡修正手術が米国だけで毎年行われています。したがって、このような事例は、時間の経過とともに業界の普及を促進すると予想されます。

さらに、湿疹やにきびなどの皮膚疾患の発生率が上昇していることから、肥厚性瘢痕やケロイドの治療に対する需要が高まると予想されます。例えば、NCBIが発表した研究によると、湿疹のある患者はケロイド状の瘢痕を形成するリスクが高いことが分かっています。また、全米湿疹協会によると、米国の総人口の約10.1%にあたる3610万人が、何らかの形で湿疹を患っているとされています。このように、湿疹の増加や湿疹によるケロイド形成のリスクは、市場の成長を促進すると予測されています。

さらに、COVID-19に苦しむ人口の減少は、業界の成長を後押しすることが予想されます。市場の企業は、パートナーシップや販売契約など、さまざまな戦略を選択しています。例えば、2021年11月、Sonoma PharmaceuticalsとDyamed Biotechは、長期的なパートナーシップの拡大を発表しました。このパートナーシップは、マレーシア、インドネシア、タイ、シンガポールなどの南アジア諸国における自社製品の利用可能性を拡大することを目的としています。したがって、このような事例は、予測期間中に業界の成長を後押しすると期待されます。

肥厚性・ケロイド性傷跡治療市場レポートハイライト。

• 傷跡のタイプでは、ケロイド傷跡セグメントが2021年に64.76%の最大シェアを占めました。これは、治りにくい性質と高い返戻率に起因するものです
• 製品別では、外用剤が2021年に40.00%以上のシェアを獲得し、製品セグメントを支配すると予想されます。これは、クリーム、ジェル、シリコーンシートなどの外用製品が容易に入手できることに起因すると考えられます。しかし、レーザー製品セグメントは、予測期間中に最も速い成長率を示すと予想されます。これは、より良い結果や良好な転帰に起因することができます。
• 最終用途に基づくと、病院セグメントが2021年に最大の市場シェアを占め、一方、小売薬局/eコマースセグメントは予測期間中に最も速い成長率を示すと予測されます。これは、顧客の利便性が高いこと、市販の割引製品が利用可能であることが要因として挙げられます。
• 北米は、同地域で行われている美容外科手術の認知度や件数が増加していることから、予測期間中、肥厚性瘢痕およびケロイド瘢痕治療の世界市場を独占すると予想されます。しかし、アジア太平洋地域は、予測期間中にCAGR 9.68%という最も速い成長率を記録すると予測されています。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • 瘢痕タイプ
  • 製品
  • 最終用途
  • 地域範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析（モデル1）
    • アプローチ1：コモディティフローアプローチ
  • 出来高価格分析（モデル2）
    • アプローチ2：出来高価格分析
• 二次情報のリスト
• 一次情報のリスト
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 肥厚性およびケロイド瘢痕治療市場の変数、動向および範囲

• 市場系列の見通し
  • 親市場の見通し
  • アンシラリー市場の見通し
• 浸透と成長の見通しのマッピング
• ユーザー視点分析
  • 消費者行動分析
  • 市場インフルエンサー分析
• 主なエンドユーザーのリスト
• 市場力学
  • 市場促進要因分析
    • 美容外科に対する意識と需要の世界の増加
    • 交通事故や火傷の増加
    • 技術的に高度な製品の入手可能性の増加
  • 市場抑制要因分析
    • レーザーベース製品の高コスト
    • 償還ポリシーの欠如
• 肥厚性およびケロイド瘢痕治療：市場分析ツール
  • 業界分析- ポーターの5つの力
  • 害虫にSWOT分析
• COVID-19が市場に与える影響

第4章 肥厚性およびケロイド瘢痕治療市場：2018年から2030年までの瘢痕タイプ別セグメント分析（100万米ドル）

• 定義と範囲
• 瘢痕タイプの市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の肥厚性およびケロイド瘢痕治療市場、瘢痕タイプ別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 肥厚性瘢痕
  • ケロイド瘢痕

第5章 肥厚性およびケロイド瘢痕治療市場：2018年から2030年の製品別セグメント分析（100万米ドル）

• 定義と範囲
• 製品市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 肥厚性およびケロイド瘢痕市場、製品別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 局所製品
  • レーザー製品
  • 注射剤
  • その他

第6章 肥厚性およびケロイド瘢痕治療市場：セグメント分析、2018年から2030年までの最終用途別（100万米ドル）

• 定義と範囲
• 最終用途の市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の肥厚性およびケロイド瘢痕市場、最終用途別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 病院
  • 診療所
  • 小売薬局/Eコマース

第7章 肥厚性およびケロイド瘢痕治療市場：地域市場分析、瘢痕タイプ別、製品別、最終用途別、2018年～2030年（100万米ドル）

• 定義と範囲
• 地域市場シェア分析、2021年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• 2018年から2030年までの市場規模、予測、量、トレンド分析
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第8章 肥厚性およびケロイド瘢痕治療市場-競合分析

• 主要な市場参加者別最近の動向と影響分析
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要企業の市場シェア分析、2021年
  • 主要取引と戦略的提携
    • 新製品の発売
    • 拡張
    • 取得
  • 市場参入戦略
• 企業プロファイル
  • Smith &Nephew
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Merz Pharmaceuticals, Llc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Lumenis
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Enaltus, LLC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Sonoma Pharmaceuticals, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Molnlycke Health Care Ab
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Suneva Medical, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Pacific World Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Perrigo Company PLC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Cynosure, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Alliance Pharma, Plc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Newmedical Technology, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America hypertrophic and keloid scar treatment market, by country, 2018 - 2030 (USD Million)
• Table 4. North America hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 5. North America hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 6. North America hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 7. U.S. hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 8. U.S. hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 9. U.S. hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 10. Canada hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 11. Canada hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 12. Canada hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 13. Europe hypertrophic and keloid scar treatment market, by country, 2018 - 2030 (USD Million)
• Table 14. Europe hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 15. Europe hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 16. Europe hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 17. U.K. hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 18. U.K. hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 19. U.K. hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 20. Germany hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 21. Germany hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 22. Germany hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 23. France hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 24. France hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 25. France hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 26. Italy hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 27. Italy hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 28. Italy hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 29. Spain hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 30. Spain hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 31. Spain hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 32. Asia Pacific hypertrophic and keloid scar treatment market, by country, 2018 - 2030 (USD Million)
• Table 33. Asia Pacific hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 34. Asia Pacific hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 35. Asia Pacific hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 36. Japan hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 37. Japan hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 38. Japan hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 39. China hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 40. China hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 41. China hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 42. India hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 43. India hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 44. India hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 45. Australia hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 46. Australia hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 47. Australia hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 48. South Korea hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 49. South Korea hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 50. South Korea hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 51. Latin America hypertrophic and keloid scar treatment market, by country, 2018 - 2030 (USD Million)
• Table 52. Latin America hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 53. Latin America hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 54. Latin America hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 55. Brazil hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 56. Brazil hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 57. Brazil hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 58. Mexico hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 59. Mexico hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 60. Mexico hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 61. Argentina hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 62. Argentina hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 63. Argentina hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 64. Colombia hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 65. Colombia hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 66. Colombia hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 67. Middle East & Africa hypertrophic and keloid scar treatment market, by country, 2018 - 2030 (USD Million)
• Table 68. Middle East & Africa hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 69. Middle East & Africa hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 70. Middle East & Africa hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 71. South Africa hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 72. South Africa hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 73. South Africa hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 74. Saudi Arabia hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 75. Saudi Arabia hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 76. Saudi Arabia hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)
• Table 77. UAE hypertrophic and keloid scar treatment market, by scar type, 2018 - 2030 (USD Million)
• Table 78. UAE hypertrophic and keloid scar treatment market, by product, 2018 - 2030 (USD Million)
• Table 79. UAE hypertrophic and keloid scar treatment market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Hypertrophic and keloid scar treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2021)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Hypertrophic and keloid scar treatment market: Scar type movement analysis
• Fig. 19 Segment dashboard
• Fig. 20 Hypertrophic and keloid scar treatment market scar type outlook: Key takeaways
• Fig. 21 Hypertrophic scars market 2018 - 2030 (USD Million)
• Fig. 22 Keloid scars market 2018 - 2030 (USD Million)
• Fig. 23 Hypertrophic and keloid scar treatment market: Product movement analysis
• Fig. 24 Segment dashboard
• Fig. 25 Hypertrophic and keloid scar treatment market product outlook: Key takeaways
• Fig. 26 Topical products market 2018 - 2030 (USD Million)
• Fig. 27 Silicone sheets market 2018 - 2030 (USD Million)
• Fig. 28 Creams market 2018 - 2030 (USD Million)
• Fig. 29 Gels market 2018 - 2030 (USD Million)
• Fig. 30 Others market 2018 - 2030 (USD Million)
• Fig. 31 Laser products market 2018 - 2030 (USD Million)
• Fig. 32 Pulse-dyed laser market 2018 - 2030 (USD Million)
• Fig. 33 CO2 laser market 2018 - 2030 (USD Million)
• Fig. 34 Others market 2018 - 2030 (USD Million)
• Fig. 35 Injectables market 2018 - 2030 (USD Million)
• Fig. 36 Others market 2018 - 2030 (USD Million)
• Fig. 37 Hypertrophic and keloid scar treatment market: End-use movement analysis
• Fig. 38 Segment dashboard
• Fig. 39 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 40 Clinics market, 2018 - 2030 (USD Million)
• Fig. 41 Retail pharmacies/e-commerce market 2018 - 2030 (USD Million)
• Fig. 42 Regional outlook, 2022 & 2030
• Fig. 43 Regional market dashboard
• Fig. 44 Regional marketplace: Key takeaways
• Fig. 45 North America hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 46 U.S hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 47 Canada hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 48 Europe hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 49 U.K hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 50 Germany hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 51 France hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 52 Italy hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 53 Spain hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 54 Asia Pacific hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 55 Japan hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 56 China hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 57 India hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 58 Australia hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 59 South Korea hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 60 Latin America hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 61 Brazil hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 62 Mexico hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 63 Argentina hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 64 Colombia hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 65 MEA hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 66 South Africa hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 67 Saudi Arabia hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 68 UAE hypertrophic and keloid scar treatment market 2018 - 2030 (USD Million)
• Fig. 69 Market differentiators
• Fig. 70 Regional network map

Hypertrophic And Keloid Scar Treatment Market Growth & Trends:

The hypertrophic and keloid scar treatment market size is anticipated to reach USD 14.60 billion by 2030 witnessing a CAGR of 8.47% during the forecast period, according to a new report by Grand View Research, Inc. This can be attributed to the rise in the number of road accidents & burn cases. For instance, according to an article by American Burn Association, more than 400,000 people are treated for burn injuries every year. Similarly, as per Children Safety Network, each year more than 100,000 children & adolescents are treated for burn injuries.

Moreover, as per National Highway Traffic Safety Administration, an estimated 31,720 people have died in road accidents in the first nine months of 2021. This number has increased by 12% as compared to 2020. Similarly, as per Live Mint, 3,54,796 cases of road accidents were reported by India in the year 2020. Thus, due to the above-mentioned factors, the t market is estimated to witness significant growth over the forecasted period.

Similarly, rising awareness regarding aesthetic appeal and availability of surgeries is expected to boost the industry's growth. For instance, as per Medscape, 200 million incisions are performed globally. Moreover, as per a similar source, an estimated 170,000 scar revision surgeries are performed every year in the U.S. alone. Thus, such instances are expected to propel industry adoption over time.

Additionally, the rising incidence rate of skin disorders such as eczema, and acne is expected to increase the demand for hypertrophic and keloid scar treatments. For instance, as per a study published by NCBI, patients with eczema are at higher risk of developing a keloid scar. Moreover, according to National Eczema Association, 36.10 million people i.e., about 10.1% of the total U.S. population have some or other form of eczema. Thus, rising cases of eczema & risk of formation of keloid scars due to it are predicted to drive the market growth.

Furthermore, the decline in the population suffering from COVID-19 is anticipated to boost the growth of the industry. Companies in the market are opting for various strategies such as partnerships, and distribution agreements. For instance, in November 2021, Sonoma Pharmaceuticals & Dyamed Biotech announced the expansion of their long-term partnership. This partnership is intended to expand the availability of their products in South Asian countries such as Malaysia, Indonesia, Thailand & Singapore. Therefore, such instances are expected to boost the growth of the industry over the forecast period.

Hypertrophic And Keloid Scar Treatment Market Report Highlights:

• In terms of scar type, the keloid scars segment held the largest share of 64.76% in 2021. This can be attributed to its hard-to-heal nature and high return rate

• Based on product, topical products are expected to dominate the product segment with a market share of more than 40.00% in 2021. This can be attributed to the easy availability of topical products such as creams, gels, and silicone sheets. However, the laser products segment is anticipated to witness the fastest growth rate over the forecast period. This can be attributed to better results and favorable outcomes

• Based on end-use, the hospitals segment held the largest market share in 2021, whereas, the retail pharmacies/e-commerce segment is projected to witness the fastest growth rate over the forecast duration. This can be attributed to greater customer convenience and availability of discount over-the-counter products

• North America is anticipated to dominate the global hypertrophic and keloid scar treatment market over the forecast period owing to the rising awareness and number of aesthetic surgeries performed in the region. However, Asia-Pacific is projected to witness the fastest growth rate of a CAGR of 9.68% over the forecast period.

Table of Contents

Chapter 1. Methodology And Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Scar Type
  • 1.1.2 Product
  • 1.1.3 End-Use
  • 1.1.4 Regional Scope
  • 1.1.5 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.6.2 Volume Price Analysis (Model 2)
    • 1.6.2.1 Approach 2: Volume Price Analysis
• 1.7 List Of Secondary Sources
• 1.8 List Of Primary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 OBJECTIVE 1
  • 1.10.2 OBJECTIVE 2
  • 1.10.3 OBJECTIVE 3
  • 1.10.4 OBJECTIVE 4

Chapter 2. Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3. Hypertrophic And Keloid Scar Treatment Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 User Perspective Analysis
  • 3.3.1 Consumer Behavior Analysis
  • 3.3.2 Market Influencer Analysis
• 3.4 List Of Key End-Users
• 3.5 Market Dynamics
  • 3.5.1 Market Driver Analysis
    • 3.5.1.1 Global Increase In Awareness & Demand For Aesthetics Surgery
    • 3.5.1.2 Increasing Number Of Road Accidents And Burn Cases
    • 3.5.1.3 Increase In Availability Of Technologically Advanced Products
  • 3.5.2 Market Restraints Analysis
    • 3.5.2.1 High Cost Of Laser-Based Products
    • 3.5.2.2 Lack Of Reimbursement Policies
• 3.6 Hypertrophic And Keloid Scar Treatment: Market Analysis Tools
  • 3.6.1 Industry Analysis - Porter's Five Forces
  • 3.6.2 Swot Analysis, By Pest
• 3.7 Impact Of COVID-19 On Market

Chapter 4. Hypertrophic And Keloid Scar Treatment Market: Segment Analysis, By Scar Type 2018 - 2030 (USD Million)

• 4.1 Definition And Scope
• 4.2 Scar Type Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Hypertrophic And Keloid Scar Treatment Market, By Scar Type, 2018 To 2030
• 4.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
  • 4.5.1 HYPERTROPHIC SCARS
    • 4.5.1.1 Hypertrophic Scars Market 2018 - 2030 (USD Million)
  • 4.5.2 KELOID SCARS
    • 4.5.2.1 Keloid Scars Market 2018 - 2030 (USD Million)

Chapter 5. Hypertrophic And Keloid Scar Treatment Market: Segment Analysis, By Product 2018 - 2030 (USD Million)

• 5.1 Definition And Scope
• 5.2 Product Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Hypertrophic And Keloid Scar Market, By Product, 2018 To 2030
• 5.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
  • 5.5.1 Topical Products
    • 5.5.1.1 Topical Market 2018 - 2030 (USD Million)
    • 5.5.1.1.1 Silicone Sheets Market 2018 - 2030 (USD Million)
    • 5.5.1.1.2 Creams Market 2018 - 2030 (USD Million)
    • 5.5.1.1.3 Gels Market 2018 - 2030 (USD Million)
    • 5.5.1.1.4 Others Market 2018 - 2030 (USD Million)
  • 5.5.2 Laser Products
    • 5.5.2.1 Laser Market 2018 - 2030 (USD Million)
    • 5.5.2.1.1 Pulse-Dyed Market 2018 - 2030 (USD Million)
    • 5.5.2.1.2 CO2 Market 2018 - 2030 (USD Million)
    • 5.5.2.1.3 Others Market 2018 - 2030 (USD Million)
  • 5.5.3 Injetables
    • 5.5.3.1 Injectables Market 2018 - 2030 (USD Million)
  • 5.5.4 Others
    • 5.5.4.1 Laser Market 2018 - 2030 (USD Million)

Chapter 6. Hypertrophic And Keloid Scar Treatment Market: Segment Analysis, By End-Use 2018 - 2030 (USD Million)

• 6.1 Definition And Scope
• 6.2 End-Use Market Share Analysis, 2021 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Hypertrophic And Keloid Scar Market, By End-Use, 2018 To 2030
• 6.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
  • 6.5.1 Hospitals
    • 6.5.1.1 Hospitals Market 2018 - 2030 (USD Million)
  • 6.5.2 Clinics
    • 6.5.2.1 Clinics Market 2018 - 2030 (USD Million)
  • 6.5.3 Retail Pharmacies/E-commerce
    • 6.5.3.1 Retail Pharmacies/E-Commerce Market 2018 - 2030 (USD Million)

Chapter 7. Hypertrophic And Keloid Scar Treatment Market: Regional Market Analysis, By Scar Type, By Product, By End-Use 2018 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2021 & 2030
• 7.3 Regional Market Dashboard
• 7.4 Regional Market Snapshot
• 7.5 Market Size, & Forecasts, Volume, And Trend Analysis, 2018 To 2030
• 7.6 North America
  • 7.6.1 North America Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD MILLION)
  • 7.6.2 U.S.
    • 7.6.2.1 U.S. Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.6.3 CANADA
    • 7.6.3.1 Canada Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
• 7.7 Europe
  • 7.7.1 Europe Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)
  • 7.7.2 U.K.
    • 7.7.2.1 U.K. Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.7.3 GERMANY
    • 7.7.3.1 Germany Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.7.4 France
    • 7.7.4.1 France Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.7.5 Italy
    • 7.7.5.1 Italy Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.7.6 Spain
    • 7.7.6.1 Spain Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
• 7.8 Asia Pacific
  • 7.8.1 Asia Pacific Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD MILLION)
  • 7.8.2 Japan
    • 7.8.2.1 Japan Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.8.3 China
    • 7.8.3.1 China (Mainland) Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.8.4 India
    • 7.8.4.1 India Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.8.5 Australia
    • 7.8.5.1 Australia Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.8.6 South Korea
    • 7.8.6.1 South Korea Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
• 7.9 Latin America
  • 7.9.1 Latin America Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)
  • 7.9.2 Brazil
    • 7.9.2.1 Brazil Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)
  • 7.9.3 Mexico
    • 7.9.3.1 Mexico Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.9.4 ARGENTINA
    • 7.9.4.1 Argentina Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
  • 7.9.5 COLOMBIA
    • 7.9.5.1 Colombia Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (USD Million)
• 7.10 MEA
  • 7.10.1 Mea Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)
  • 7.10.2 South Africa
    • 7.10.2.1 South Africa Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)
  • 7.10.7 Saudi Arabia
    • 7.10.7.1 Saudi Arabia Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)
  • 7.10.8 UAE
    • 7.10.8.1 UAE Hypertrophic And Keloid Scar Treatment Market 2018 - 2030 (Usd Million)

Chapter 8. Hypertrophic And Keloid Scar Treatment Market - Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, By Key Market Participants
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 Key Company Market Share Analysis, 2021
  • 8.3.2 Major Deals And Strategic Alliances
    • 8.3.2.1 New Product Launch
    • 8.3.2.2 Expansion
    • 8.3.2.3 Acquisition
  • 8.3.3 Market Entry Strategies
• 8.4 Company Profiles
  • 8.4.1 Smith & Nephew
    • 8.4.1.1 Company Overview
    • 8.4.1.2 Financial Performance
    • 8.4.1.3 Product Benchmarking
    • 8.4.1.4 Strategic Initiatives
  • 8.4.2 Merz Pharmaceuticals, Llc.
    • 8.4.2.1 Company Overview
    • 8.4.2.2 Financial Performance
    • 8.4.2.3 Product Benchmarking
    • 8.4.2.4 Strategic Initiatives
  • 8.4.3 Lumenis
    • 8.4.3.1 Company Overview
    • 8.4.3.2 Financial Performance
    • 8.4.3.3 Product Benchmarking
    • 8.4.3.4 Strategic Initiatives
  • 8.4.4 Enaltus, LLC
    • 8.4.4.1 Company Overview
    • 8.4.4.2 Financial Performance
    • 8.4.4.3 Product Benchmarking
    • 8.4.4.4 Strategic Initiatives
  • 8.4.5 Sonoma Pharmaceuticals, Inc.
    • 8.4.5.1 Company Overview
    • 8.4.5.2 Financial Performance
    • 8.4.5.3 Product Benchmarking
    • 8.4.5.4 Strategic Initiatives
  • 8.4.6 Molnlycke Health Care Ab
    • 8.4.6.1 Company Overview
    • 8.4.6.2 Financial Performance
    • 8.4.6.3 Product Benchmarking
    • 8.4.6.4 Strategic Initiatives
  • 8.4.7 Suneva Medical, Inc.
    • 8.4.7.1 Company Overview
    • 8.4.7.2 Financial Performance
    • 8.4.7.3 Product Benchmarking
    • 8.4.7.4 Strategic Initiatives
  • 8.4.8 Pacific World Corporation
    • 8.4.8.1 Company Overview
    • 8.4.8.2 Financial Performance
    • 8.4.8.3 Product Benchmarking
    • 8.4.8.4 Strategic Initiatives
  • 8.4.9 Perrigo Company PLC
    • 8.4.9.1 Company Overview
    • 8.4.9.2 Financial Performance
    • 8.4.9.3 Product Benchmarking
    • 8.4.9.4 Strategic Initiatives
  • 8.4.10 Cynosure, Inc.
    • 8.4.10.1 Company Overview
    • 8.4.10.2 Financial Performance
    • 8.4.10.3 Product Benchmarking
    • 8.4.10.4 Strategic Initiatives
  • 8.4.11 Alliance Pharma, Plc
    • 8.4.11.1 Company overview
    • 8.4.11.2 Financial performance
    • 8.4.11.3 Product benchmarking
    • 8.4.11.4 Strategic initiatives
  • 8.4.12 Newmedical Technology, Inc.
    • 8.4.12.1 Company Overview
    • 8.4.12.2 Financial Performance
    • 8.4.12.3 Product Benchmarking
    • 8.4.12.4 Strategic Initiatives